Á lódáil...
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ
Nilotinib and imatinib are tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). In vitro, imatinib and nilotinib inhibit osteoclastogenesis, and in patients they reduce levels of bone resorption. One of the mechanisms t...
Na minha lista:
| Foilsithe in: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Public Library of Science
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5063333/ https://ncbi.nlm.nih.gov/pubmed/27737004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0164727 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|